- £137.02m
- £140.33m
- £0.27m
REG-4basebio Plc: Development of GMP Manufacturing Capacity
AnnouncementREG - 4Basebio PLC - Second Price Monitoring Extn
AnnouncementREG - 4Basebio PLC - Price Monitoring Extension
AnnouncementREG-4basebio UK Societas: Further re Conversion to UK PLC
AnnouncementREG-4basebio UK Societas: Conversion to UK PLC
AnnouncementREG-4basebio UK Societas: Director/PDMR Shareholding
AnnouncementREG-4basebio UK Societas: Result of AGM
AnnouncementREG-4basebio UK Societas: Application filed for protected linearised synthetic DNA
AnnouncementREG-4basebio UK Societas: Annual General Meeting 2021
AnnouncementREG-4basebio UK Societas: Notice of AGM and Posting of Accounts
AnnouncementREG-4basebio UK Societas: Final Results
AnnouncementREG-4basebio UK Societas: Evaluation licence for muscular dystrophy vector
AnnouncementREG-4basebio UK Societas: Director/PDMR Shareholding
AnnouncementREG - 4Basebio UK Societas - Price Monitoring Extension
AnnouncementREG - 4Basebio UK Societas - Second Price Monitoring Extn
Announcement